Bicalutamide, sold under the brand name Casodex among others, is an antiandrogen medication that is primarily used to treat prostate cancer. It is typically...
216 KB (21,601 words) - 09:16, 19 July 2024
Comparison of the nonsteroidal antiandrogen (NSAA) bicalutamide with other antiandrogens reveals differences between the medications in terms of efficacy...
85 KB (8,742 words) - 03:27, 16 August 2024
The side effects of bicalutamide, a nonsteroidal antiandrogen (NSAA), including its frequent and rare side effects, have been well-studied and characterized...
140 KB (15,722 words) - 03:49, 24 June 2024
pharmacology of bicalutamide is the study of the pharmacodynamic and pharmacokinetic properties of the nonsteroidal antiandrogen (NSAA) bicalutamide. In terms...
185 KB (20,447 words) - 15:57, 1 August 2024
The medical uses of bicalutamide, a nonsteroidal antiandrogen (NSAA), include the treatment of androgen-dependent conditions and hormone therapy to block...
133 KB (13,441 words) - 19:13, 1 February 2024
5N-Bicalutamide, or 5-azabicalutamide, is a highly potent nonsteroidal antiandrogen (NSAA) which was discovered in 2016. It is a structural modification...
5 KB (400 words) - 10:45, 3 November 2023
Vergunst H, Mulders PF (2016). "The AVOCAT study: Bicalutamide monotherapy versus combined bicalutamide plus dutasteride therapy for patients with locally...
31 KB (3,433 words) - 01:04, 23 June 2024
to bicalutamide where the expression was upregulated. In VCaP cells which over-express the AR, enzalutamide induced apoptosis whereas bicalutamide did...
50 KB (4,674 words) - 20:52, 20 August 2024
high-dosage bicalutamide therapy plus dutasteride showed less sexual dysfunction than medical castration similarly to high-dosage bicalutamide monotherapy...
48 KB (5,709 words) - 11:12, 22 June 2024
treatments. When castration is combined with a nonsteroidal antiandrogen like bicalutamide, this strategy is referred to as combined androgen blockade (also known...
158 KB (15,043 words) - 06:11, 3 August 2024